Continuous vectorcardiography ischemic monitoring (VCG) is a noninvasive technique which has contributed much to our understanding of the dynamics of acute coronary syndromes. For risk assessment of patients with unstable angina pectoris or non-Q-wave myocardial infarction, VCG shows important prognostic power which is further enhanced by its combination with the measurement of highly sensitive and specific biochemical markers of myocardial injury. VCG surveillance after revascularization therapy of Q-wave myocardial infarction is widely accepted because of its potential of assessing vessel patency, of estimating infarct size, and of revealing residual myocardial ischemia. Valuable prognostic information is available in real time with VCG, and treatment strategies may be based upon more reliable grounds. In this survey, the VCG technique is presented together with the most frequently used vectorcardiographic variables. Further, the use of the method for risk stratification of patients with unstable coronary syndromes is also described.

1.
Fragmin during Instability in Coronary Artery Disease (FRISC) Study Group: Low-molecular-weight heparin during instability in coronary artery disease. Lancet 1996;347:561–568.
2.
Klein W, Buchwald A, Hillis SE, Monrad S, Sanz G, Turpie GG, van der Meer J, Olaisson E, Undeland S, Ludwig K for the FRIC Investigators: Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease: Fragmin in Unstable Coronary Artery Disease Study (FRIC). Circulation 1997;96:61–68.
3.
Gazes PC, Mobley EM Jr, Faris HM Jr, Duncan RC, Humphries GB: Preinfarctional (unstable) angina – a prospective study – ten-year follow-up: Prognostic significance of electrocardiographic changes. Circulation 1973;48:331–337.
4.
Nyman I, Areskog M, Areskog N-H, Swahn E, Wallentin L, and the RISC Study Group: Very early risk stratification by electrocardiogram at rest in men with suspected unstable coronary heart disease. J Intern Med 1993;234:293–301.
5.
Wilcox I, Freedman SB, Allman KC, Collins FL, Leitch JW, Kelly D, Harris PJ: Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectoris. J Am Coll Cardiol 1991;18:677–683.
6.
Lindahl B, Andren B, Ohlsson J, Venge P, Wallentin L for the FRISC Study Group: Risk stratification in unstable coronary artery disease: Additive value of troponin T determinations and predischarge exercise tests. Eur Heart J 1997;18:762–770.
7.
Johnson SM, Mauritson DR, Winniford MD, Willerson JT, Firth BG, Cary JR, Hillis LD: Continuous electrocardiographic monitoring in patients with unstable angina pectoris: Identification of high-risk subgroup with severe coronary disease, variant angina, and/or impaired early prognosis. Am Heart J 1982;103:4–12.
8.
Gottlieb SO, Gottlieb SH, Achuff SC, Baumgardner R, Mellits ED, Weisfeldt ML, Gerstenblith G: Silent ischemia on Holter monitoring predicts mortality in high-risk postinfarction patients. JAMA 1988;259:1030–1035.
9.
Patel DJ, Holdright DR, Knight CJ, Mulcahy D, Thakrar B, Wright C, Sparrow J, Wicks M, Hubbard W, Thomas R, Sutton GC, Hendry G, Purcell H, Fox K: Early continuous ST-segment monitoring in unstable angina: Prognostic value additional to the clinical characteristics and the admission electrocardiogram. Heart 1996;75:222–228.
10.
Dellborg M, Riha M, Swedberg K for the TEAHAT Study Group: Dynamic QRS-complex and ST-segment monitoring in acute myocardial infarction during recombinant tissue-type plasminogen activator therapy. Am J Cardiol 1991;67:343–349.
11.
Lundin P, Eriksson SV, Erhardt L, Strandberg LE, Rehnquist N: Continuous vectorcardiography in patients with chest pain indicative of acute ischemic heart disease. Cardiology 1992;81:145–156.
12.
Lundin P, Eriksson SV, Strandberg LE, Rehnquist N: Prognostic information from on-line vectorcardiography in acute myocardial infarction. Am J Cardiol 1994;74:1103–1108.
13.
Lundin P, Eriksson SV, Fredriksson M, Rehnquist N: Prognostic information from on-line vectorcardiography in unstable angina pectoris. Cardiology 1995;86:60–66.
14.
Dellborg M, Malmberg K, Ryden L, Svensson A-M, Swedberg K: Dynamic on-line vectorcardiography improves and simplifies in-hospital ischemia monitoring of patients with unstable angina. J Am Coll Cardiol 1995;26:1501–1507.
15.
Dellborg M, Steg PG, Simoons M, Dietz R, Sens S, van den Brand M, Lotze U, Hauck S, van den Wieken R, Himbert D, Svensson A-M, Swedberg K: Vectorcardiographic monitoring to assess early vessel patency after reperfusion therapy for acute myocardial infarction. Eur Heart J 1995;16:21–29.
16.
Andersen K, Eriksson P, Dellborg M: Non-invasive risk stratification within 48 hours of hospital admission in patients with unstable coronary disease. Eur Heart J 1997;18:780–788.
17.
Abrahamsson P, Dellborg M, Andersen K: Prognostic value of maximum ST-vector magnitude during the first 24 hours of vectorcardiographic monitoring in patients with unstable angina pectoris. Eur Heart J 1999;20:1166–1174.
18.
Lundin P, Jensen J, Lindahl B, Wallentin L, Eriksson SV: Prognostic value of ischemia monitoring with on-line vectorcardiography in patients with unstable coronary artery disease. Cardiology 2000;93:183–190.
19.
Nørgaard BL, Andersen K, Dellborg M, Abrahamsson P, Ravkilde J, Thygesen K: Admission risk assessment by cardiac troponin T in unstable coronary artery disease: Additional prognostic information from continuous ST-segment monitoring. J Am Coll Cardiol 1999;33:1519–1527.
20.
Gill S: Early Noninvasive Findings in the Acute Ischemic Syndrome and Their Significance for Long-Term Prognosis with Special Focus on Continuous Dynamic Vectorcardiography; thesis Odense University, Odense, 2000.
21.
Jensen SM, Johansson G, Osterman G, Reiz S, Näslund U: On-line computerized vectorcardiography monitoring of myocardial ischemia during coronary angioplasty: Comparison with 12-lead electrocardiography. Coron Artery Dis 1994;5:507–514.
22.
Abrahamsson P: On the Prognosis and Risk Assessment in the Unstable Coronary Syndrome; thesis Göteborg University, Göteborg, 1999.
23.
Klootwijk P, Meijs S, von Es GA, Müller EJ, Umans VAWM, Lenderink T, Simoons ML: Comparison of usefulness of computer assisted continuous 48-h 3-lead with 12-lead ECG ischaemia monitoring for detection and quantitation of ischaemia in patients with unstable angina. Eur Heart J 1997;18:931–940.
24.
Krucoff MW, Croll M, Pope J, Pieper KS, Kanani PM, Granger CB, Veldkamp RF, Wagner BL, Sawchak ST, Califf RM: Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations. Am J Cardiol 1993;71:145–151.
25.
Krucoff MW, Wagner NB, Pope JE, Mortara DM, Jackson YR, Bottner RK, Wagner GS, Kent KM: The portable programmable microprocessor-driven real-time 12-lead electrocardiographic monitor: A preliminary report of a new device for the noninvasive detection of successful reperfusion or silent coronary reocclusion. Am J Cardiol 1990;65:143–148.
26.
Langer A, Krucoff MW, Klootwijk P, Simoons ML, Granger CB, Barr A, Calif RM, Armstrong PW for the GUSTO-I ECG Monitoring Substudy Group: Prognostic significance of ST segment shift early after resolution of elevation in patients with myocardial infarction treated with thrombolytic therapy: The GUSTO-I ST Segment Monitoring Substudy. J Am Coll Cardiol 1998;31:783–789.
27.
Jernberg T, Lindahl B, Wallentin L: ST-segment monitoring with continuous 12-lead ECG improves early risk stratification in patients with chest pain and ECG nondiagnostic of acute myocardial infarction. J Am Coll Cardiol 1999;34:1413–1419.
28.
Shar A, Wagner GS, Granger CG, O’Connor CM, Green CL, Trollinger KM, Califf RM, Krucoff MW: Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis: Reexamining the ‘gold standard’ for myocardial reperfusion assessment. J Am Coll Cardiol 2000;35:666–672.
29.
Ravkilde J, Nissen H, Hørder M, Thygesen K: Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction: Analysis of 28 months follow-up in 196 patients. J Am Coll Cardiol 1995;25:574–581.
30.
Mazeika PK, Nadazdin A, Oakley CM: Prognostic value of dobutamine echocardiography in patients with high pretest likelihood of coronary artery disease. Am J Cardiol 1993;71:33–39.
31.
Miller DD, Stratmann HG, Shaw L, Tamesis BR, Wittry MD, Younis LT, Chaitman BR: Dipyridamole technetium 99m sestamibi myocardial tomography as an independent predictor of cardiac event-free survival after acute ischemic events. J Nucl Cardiol 1994;1:72–82.
32.
Frank E: Accurate, clinically practical system for spatial vectorcardiography. Circulation 1956;13:737–744.
33.
Dower GE, Yakush A, Nazzal SB, Jutzy RV, Ruiz CE: Deriving the 12-lead electrocardiogram from four (EASI) electrodes. J Electrocardiol 1988;21(suppl):183–187.
34.
Näslund U, Häggmark S, Johansson G, Reiz S: Quantification of myocardium at risk and detection of reperfusion by dynamic vectorcardiographic ST-segment monitoring in a pig occlusion-reperfusion model. Cardiovasc Res 1993;27:2170–2178.
35.
Nørgaard BL, Rasmussen BM, Dellborg M, Thygesen K: Positional changes of spatial QRS- and ST-segment variables in normal subjects: Implications for continuous vectorcardiography monitoring during myocardial ischemia. J Electrocardiol 2000;33:23–30.
36.
Dellborg M, Emanuelsson H, Riha M, Swedberg K: Dynamic QRS and ST-segment monitoring by continuous vectorcardiography during coronary angioplasty. Coron Artery Dis 1991;2:43–52.
37.
Dellborg M, Gustafsson G, Riha M, Swedberg K: Dynamic changes of the QRS complex in unstable angina pectoris. Int J Cardiol 1992;36:151–162.
38.
van’t Hof AWJ, Liem A, de Boer M-J, Zijlstra F for the Zwolle Myocardial Infarction Study Group: Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet 1997;350:615–619.
39.
Ohman EM, Califf RM, Topol EJ, Candela R, Abbottsmith C, Ellis S, Sigmon KN, Kereiakes D, George B, Stack R for the TAMI Study Group: Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation 1990;82:781–791.
40.
Sederholm M, Gröttum P, Erhardt L, Kjekshus J: Quantitative assessment of myocardial ischemia and necrosis by continuous vectorcardiography and measurement of creatine kinase release in patients. Circulation 1983;68:1006–1012.
41.
Nørgaard BL, Rasmussen BM, Dellborg M, Thygesen K: Temporal and positional variability of the ST segment during continuous vectorcardiography monitoring in healthy subjects. J Electrocardiol 1999;32:149–158.
42.
Jensen SM, Häggmark S, Johansson G, Näslund U: On-line computerized vectorcardiography: Influence of body position, heart rate, radiographic contrast fluid and myocardial ischemia. Cardiology 1997;88:576–584.
43.
Eriksson P: Ischemic Heart Disease in Patients with Bundle-Branch Block; thesis Göteborg University, Göteborg, 1998.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.